Lisata Therapeutics, Inc.
LSTA
$1.93
$0.031.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.24M | -18.92M | -19.31M | -19.99M | -20.74M |
| Total Depreciation and Amortization | 172.00K | 170.00K | 171.00K | 174.00K | 180.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.48M | 1.53M | 1.42M | 1.33M | 994.00K |
| Change in Net Operating Assets | -640.00K | 819.00K | -9.00K | -873.00K | 669.00K |
| Cash from Operations | -17.23M | -16.40M | -17.73M | -19.36M | -18.90M |
| Capital Expenditure | -28.00K | -28.00K | -28.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.50M | 5.05M | 16.26M | 13.23M | 6.13M |
| Cash from Investing | 16.48M | 5.02M | 16.23M | 13.23M | 6.13M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 683.00K | 330.00K | 288.00K | 68.00K | 56.00K |
| Repurchase of Common Stock | -385.00K | -385.00K | -375.00K | -274.00K | -142.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 298.00K | -55.00K | -87.00K | -206.00K | -86.00K |
| Foreign Exchange rate Adjustments | -56.00K | -19.00K | 2.00K | -55.00K | -66.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -511.00K | -11.46M | -1.59M | -6.38M | -12.92M |